|Articles|January 1, 2014
- BioPharm International-01-01-2014
- Volume 27
- Issue 1
BioPharm International, January 2014 Issue (PDF)
Click the title above to open the BioPharm International January 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 12 years ago
Best Practices in Adopting Single-Use Systemsalmost 12 years ago
Drugs, At What Cost?almost 12 years ago
2014 Manufacturing Trends and Outlookalmost 12 years ago
Early Communication with Regulators is Essential for SMEsalmost 12 years ago
Downstream Purification and Formulation of Fab Antibody Fragmentsalmost 12 years ago
Life-Sciences IPOs Take a Breatheralmost 12 years ago
Innovation and Market Growth in Brazilalmost 12 years ago
Progress in the Prediction of Protein Aggregationalmost 12 years ago
Metrics Sought to Ensure Drug QualityNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Implementing Automation and Flexible Design for Allogeneic Manufacturing
2
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
3
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
4
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
5

